Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Iscoe

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
A phase II study of weekly edatrexate (10-EDAM) in metastatic melanoma. A National Cancer Institute of Canada Clinical Trials Group studyS Verma, I C Quirt, E A Eisenhauer, et al.
Medical Care|May 1, 2001
Trends in hormonal management of prostate cancer: a population-based study in OntarioS J Bondy, N A Iscoe, D M Rothwell, et al.
Cancer|April 1, 1994
Extragonadal germ cell tumors. A 14-year Toronto experienceP E Goss, L Schwertfeger, M E Blackstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials GroupJ J Rusthoven, I C Quirt, N A Iscoe, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
A phase II study of weekly edatrexate (10-EDAM) in metastatic melanoma. A National Cancer Institute of Canada Clinical Trials Group studyS Verma, I C Quirt, E A Eisenhauer, et al.
Medical Care|May 1, 2001
Trends in hormonal management of prostate cancer: a population-based study in OntarioS J Bondy, N A Iscoe, D M Rothwell, et al.
Cancer|April 1, 1994
Extragonadal germ cell tumors. A 14-year Toronto experienceP E Goss, L Schwertfeger, M E Blackstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials GroupJ J Rusthoven, I C Quirt, N A Iscoe, et al.
Pageof 2